Asthma is defined as a chronic inflammatory process, which leads to airflow limitation and increased responsiveness to asthma triggers. Until now, routine assessment of the level of inflammation has not been possible.

Controlling the inflammation, rather than its consequences, can dramatically improve the treatment and care of your asthma patients.

Relying on the patient’s history, subjective evaluation of current symptoms and lung function test results is considered reactive symptom control.

Be proactive - measure what really matters - exhaled Nitric Oxide (eNO) for inflammation status. This means that you can detect a deterioration in the patient’s asthma before it causes problems.

Inflammation measurement with NIOX MINO offers personalized asthma care that can dramatically improve the treatment and care of your patients.

It takes less than two minutes to get an eNO value of the inflammation. With results in hand, you and your patient get immediate feedback on the inflammatory status. The patient’s understanding of the disease improves, which results in better adherence to treatment.

The value you get from NIOX MINO, the NIOX Value, is always quality assured. Various factors can influence the measurement of the patient’s inflammation. An accurate and reliable eNO value is vitally important for both the physician and the patient.

The NIOX Value together with other diagnostic parameters is the basis for important decisions concerning the patient’s asthma management program.

NIOX MINO has a built-in, highly sensitive quality assurance system that will always guarantee an exact and accurate measurement that can be relied upon - The NIOX Value.